Publications
- Regorafenib for metastatic colorectal cancer: An analysis of a registry-based cohort of 555 patients2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Safety and effectiveness of aflibercept + fluorouracil, leucovorin, and irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) in current clinical practice: OZONE study2020 | Publication without faculty affiliation
- Komentář ke studii: Sledování biomarkerů ve studii VELOUR - vliv mutací RAS, BRAF a lokalizace nádoru na účinnost léčby afliberceptem2018 | Publication without faculty affiliation
- Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry2017 | First Faculty of Medicine
- Klinická onkologie2023 | Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Options and rationale for reinstituting anti-EGFR therapy in pretreated RAS wild-type advanced colorectal carcinomas2023 | Publication without faculty affiliation
- Nové trendy v léčbě pokročilého kolorektálního karcinomu2023 | Publication without faculty affiliation
- Indications for venous access in oncology - recommendations of national professional societies and current state in the Czech Republic2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Nanoliposomal irinotecan in patients with pancreatic cancer - overall survival and results of patients treated according to the protocol in the NAPOLI-1 study2021 | Publication without faculty affiliation
- Possibilities and substantiation of re-treatment with anti-EGFR drugs for pre-treated RAS wild-type advanced colorectal cancers2021 | Publication without faculty affiliation
Loading network view...